These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31913974)

  • 1. An Inpatient Psychiatric Program Targeting Opioid Overdoses.
    Mahgoub N; O'Connell K; Gevint K; Dedonatis A; Velasco J; Tham A; Cangemi S; Tai FJ; Stellman M; Radosta M; Anthony D
    J Psychiatr Pract; 2020 Jan; 26(1):71-75. PubMed ID: 31913974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In brief: Higher-dose naloxone nasal spray (Kloxxado) for opioid overdose.
    Med Lett Drugs Ther; 2021 Sep; 63(1633):151-152. PubMed ID: 34550963
    [No Abstract]   [Full Text] [Related]  

  • 3. Higher-Dose Naloxone Nasal Spray (Kloxxado) for Opioid Overdose.
    JAMA; 2021 Nov; 326(18):1853-1854. PubMed ID: 34751711
    [No Abstract]   [Full Text] [Related]  

  • 4. New Naloxone Concentration Treats Opioid Overdose.
    Aschenbrenner DS
    Am J Nurs; 2022 Feb; 122(2):25. PubMed ID: 35085146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies and policies to address the opioid epidemic: A case study of Ohio.
    Penm J; MacKinnon NJ; Boone JM; Ciaccia A; McNamee C; Winstanley EL
    J Am Pharm Assoc (2003); 2017; 57(2S):S148-S153. PubMed ID: 28189539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a collaborative model for opioid overdose prevention on campus.
    Hill LG; Holleran Steiker LK; Mazin L; Kinzly ML
    J Am Coll Health; 2020 Apr; 68(3):223-226. PubMed ID: 30615573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone Counseling for Harm Reduction and Patient Engagement.
    Han JK; Hill LG; Koenig ME; Das N
    Fam Med; 2017 Oct; 49(9):730-733. PubMed ID: 29045991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nalmefene nasal spray (Opvee) for reversal of opioid overdose.
    Med Lett Drugs Ther; 2023 Oct; 65(1687):166-167. PubMed ID: 37871116
    [No Abstract]   [Full Text] [Related]  

  • 9. The Opioid Crisis, Centers for Disease Control Opioid Guideline, and Naloxone Coprescription for Patients at Risk for Opioid Overdose.
    Benzon HT; Sun EC; Chou R
    Anesth Analg; 2022 Jul; 135(1):21-25. PubMed ID: 35709441
    [No Abstract]   [Full Text] [Related]  

  • 10. Naloxone's role in the national opioid crisis-past struggles, current efforts, and future opportunities.
    Bennett AS; Elliott L
    Transl Res; 2021 Aug; 234():43-57. PubMed ID: 33684591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
    Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
    J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding Access to Naloxone: A Necessary Step to Curb the Opioid Epidemic.
    Houser R
    Disaster Med Public Health Prep; 2022 Sep; 17():e245. PubMed ID: 36172901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality.
    Kim D; Irwin KS; Khoshnood K
    Am J Public Health; 2009 Mar; 99(3):402-7. PubMed ID: 19150908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia.
    Kanter K; Gallagher R; Eweje F; Lee A; Gordon D; Landy S; Gasior J; Soto-Calderon H; Cronholm PF; Cocchiaro B; Weimer J; Roth A; Lankenau S; Brenner J
    Harm Reduct J; 2021 Jul; 18(1):75. PubMed ID: 34301246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System.
    Grover JM; Alabdrabalnabi T; Patel MD; Bachman MW; Platts-Mills TF; Cabanas JG; Williams JG
    Prehosp Emerg Care; 2018; 22(3):281-289. PubMed ID: 29297739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone (Narcan) nasal spray for opioid overdose.
    Med Lett Drugs Ther; 2016 Jan; 58(1485):1-2. PubMed ID: 26714239
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.
    Avetian GK; Fiuty P; Mazzella S; Koppa D; Heye V; Hebbar P
    Curr Med Res Opin; 2018 Apr; 34(4):573-576. PubMed ID: 28535115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone for Opioid Overdose and the Role of the Pharmacist.
    Toderika Y; Williams S
    Consult Pharm; 2018 Feb; 33(2):98-104. PubMed ID: 29409576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Overdose and Naloxone Kit Distribution: A Quality Assurance Educational Program in the Primary Care Setting.
    Lockett TL; Hickman KL; Fils-Guerrier BJ; Lomonaco M; Maye JP; Rossiter AG
    J Addict Nurs; 2018; 29(3):157-162. PubMed ID: 30180000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.